{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T12:31:35Z","timestamp":1794486695568,"version":"4.9.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T00:00:00Z","timestamp":1613174400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T00:00:00Z","timestamp":1613174400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Down syndrome (DS) is associated with various congenital anomalies and metabolic alterations, such as dyslipidemias, that can lead to cardiovascular disease in adulthood. This study was designed to describe the lipid concentrations and the frequency of dyslipidemias in children with DS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and methods<\/jats:title>\n                <jats:p>The sample included 386 patients, 52.4% male. The study was carried out on children with DS, aged 2\u201318\u2009years old, who were patients at the Mexican National Institute of Pediatrics between May 2016 and June 2017. Their height and weight were recorded, and their serum cholesterol, HDL cholesterol, and triglyceride levels were determined.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of the total patients included, 57.5% had some type of dyslipidemia, 32.6% isolated and 24.9% combined. The most common alteration, considering both isolated and combined dyslipidemias, was low HDL, in 45.9%, followed by hypertriglyceridemia, in 26.2%. Among those with combined dyslipidemia, high TG with low HDL-c was the most common, in 17.9%. A significant association was found between dyslipidemia and obesity, as well as between dyslipidemia and central obesity. The percentiles of lipid values are reported.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The presence of an unfavorable lipid profile is common in pediatric patients with Down syndrome, especially low HDL cholesterol and high triglycerides.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12887-021-02542-1","type":"journal-article","created":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T20:42:10Z","timestamp":1613248930000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Lipid profile of Mexican children with Down syndrome"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3559-2301","authenticated-orcid":false,"given":"Silvestre","family":"Garcia-de la Puente","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1939-7074","authenticated-orcid":false,"given":"Karla A.","family":"Flores-Arizmendi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda J.","family":"Delgado-Montemayor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2365-1629","authenticated-orcid":false,"given":"Tania T.","family":"Vargas-Robledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,13]]},"reference":[{"issue":"12","key":"2542_CR1","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1002\/bdra.20735","volume":"88","author":"SE Parker","year":"2010","unstructured":"Parker SE, Mai CT, Canfield MA, et al. Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res A Clin Mol Teratol. 2010;88(12):1008\u201316. https:\/\/doi.org\/10.1002\/bdra.20735.","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"1","key":"2542_CR2","first-page":"49","volume":"24","author":"AV Zamorano","year":"1991","unstructured":"Zamorano AV, Guzman MT, Aspillaga MH, et al. Concentraciones de lipidos sericos en ninos con sindrome de Down. [Concentrations of serum lipids in Children with Down syndrome.]. Arch Biol Med Exp (Santiago). 1991;24(1):49\u201355.","journal-title":"Arch Biol Med Exp (Santiago)"},{"issue":"5","key":"2542_CR3","doi-asserted-by":"publisher","first-page":"595","DOI":"10.4067\/S0370-41062017000500004","volume":"88","author":"MJ De la Piedra","year":"2017","unstructured":"De la Piedra MJ, Alberti G, Cerda J, et al. High frequency of dyslipidemia in children and adolescents with Down syndrome. Rev Chil Pediatr. 2017;88(5):595\u2013601.","journal-title":"Rev Chil Pediatr"},{"issue":"8","key":"2542_CR4","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.ejmg.2016.06.005","volume":"59","author":"PS Buonuomo","year":"2016","unstructured":"Buonuomo PS, Bartuli A, Mastrogiorgio G, et al. Lipid profiles in a large cohort of Italian children with Down syndrome. Eur J Med Genet. 2016;59(8):392\u20135. https:\/\/doi.org\/10.1016\/j.ejmg.2016.06.005.","journal-title":"Eur J Med Genet"},{"issue":"6","key":"2542_CR5","doi-asserted-by":"publisher","first-page":"e1382","DOI":"10.1542\/peds.2011-1262","volume":"129","author":"T Adelekan","year":"2012","unstructured":"Adelekan T, Magge S, Shults J, Stallings V, Stettler N. Lipid profiles of children with Down syndrome compared with their siblings. Pediatrics. 2012;129(6):e1382\u20137. https:\/\/doi.org\/10.1542\/peds.2011-1262.","journal-title":"Pediatrics."},{"issue":"6","key":"2542_CR6","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499\u2013502.","journal-title":"Clin Chem"},{"issue":"9","key":"2542_CR7","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.clinbiochem.2004.03.008","volume":"37","author":"AJ Tremblay","year":"2004","unstructured":"Tremblay AJ, Morrissette H, Gagn\u00e9 JM, Bergeron J, Gagn\u00e9 C, Couture P. Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with beta-quantification in a large population. Clin Biochem. 2004;37(9):785\u201390. https:\/\/doi.org\/10.1016\/j.clinbiochem.2004.03.008.","journal-title":"Clin Biochem"},{"issue":"7244","key":"2542_CR8","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1136\/bmj.320.7244.1240","volume":"320","author":"TJ Cole","year":"2000","unstructured":"Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ. 2000;320(7244):1240\u20133. https:\/\/doi.org\/10.1136\/bmj.320.7244.1240.","journal-title":"BMJ."},{"issue":"7612","key":"2542_CR9","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1136\/bmj.39238.399444.55","volume":"335","author":"TJ Cole","year":"2007","unstructured":"Cole TJ, Flegal KM, Nicholls D, Jackson AA. Body mass index cut offs to define thinness in children and adolescents: international survey. BMJ. 2007;335(7612):194. https:\/\/doi.org\/10.1136\/bmj.39238.399444.55.","journal-title":"BMJ."},{"issue":"Suppl 5","key":"2542_CR10","doi-asserted-by":"publisher","first-page":"S213","DOI":"10.1542\/peds.2009-2107C","volume":"128 Suppl 5","author":"Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute","year":"2011","unstructured":"Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011;128 Suppl 5(Suppl 5):S213\u201356. https:\/\/doi.org\/10.1542\/peds.2009-2107C.","journal-title":"Pediatrics"},{"issue":"3","key":"2542_CR11","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/s0002-9378(97)70544-1","volume":"176","author":"L Bocconi","year":"1997","unstructured":"Bocconi L, Nava S, Fogliani R, Nicolini U. Trisomy 21 is associated with hypercholesterolemia during intrauterine life. Am J Obstet Gynecol. 1997; m J Obstet Gynecol. 1997 Mar;176(3):540\u20133. https:\/\/doi.org\/10.1016\/s0002-9378(97)70544-1.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"2542_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0119877","volume":"10","author":"MDM Bibiloni","year":"2015","unstructured":"Bibiloni MDM, Salas R, Novelo HI, Villarreal JZ, Sureda A, Tur JA. Serum lipid levels and dyslipidaemia prevalence among 2-10 year-old northern Mexican children. PLoS One. 2015;10(3):1\u201314. https:\/\/doi.org\/10.1371\/journal.pone.0119877.","journal-title":"PLoS One"},{"issue":"6","key":"2542_CR13","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1001\/jama.2012.9136","volume":"308","author":"BK Kit","year":"2012","unstructured":"Kit BK, Carroll MD, Lacher DA, Sorlie PD, DeJesus JM, Ogden C. Trends in serum lipids among US youths aged 6 to 19 years, 1988-2010. JAMA. 2012;308(6):591\u2013600. https:\/\/doi.org\/10.1001\/jama.2012.9136.","journal-title":"JAMA"},{"key":"2542_CR14","doi-asserted-by":"publisher","first-page":"823","DOI":"10.4067\/S0034-98872005000700011","volume":"133","author":"EM Laris","year":"2005","unstructured":"Laris EM, Arteaga LA, Cuevas MA, et al. El colesterol HDL: \u00bfun nuevo objetivo terap\u00e9utico en el manejo de las dislipidemias y la ateroesclerosis?. [HDL cholesterol: A new therapeutic objective in the management of dyslipidemias and atherosclerosis?]. Rev M\u00e9d Chile. 2005;133:823\u201332. https:\/\/doi.org\/10.4067\/S0034-98872005000700011.","journal-title":"Rev M\u00e9d Chile"},{"issue":"1","key":"2542_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/s0025-7125(05)70206-6","volume":"84","author":"DJ Rader","year":"2000","unstructured":"Rader DJ, Rosas S. Management of selected lipid abnormalities. Hypertriglyceridemia, low HDL cholesterol, lipoprotein(a), in thyroid and renal diseases, and post-transplantation. Med Clin North Am. 2000;84(1):43\u201361. https:\/\/doi.org\/10.1016\/s0025-7125(05)70206-6.","journal-title":"Med Clin North Am"},{"key":"2542_CR16","volume-title":"Encuesta Nacional de Salud y Nutrici\u00f3n [National Survey of Health and Nutrition] Ensanut","author":"ENSANUT 2018","year":"2018","unstructured":"ENSANUT 2018. Encuesta Nacional de Salud y Nutrici\u00f3n [National Survey of Health and Nutrition] Ensanut 2018."},{"issue":"2","key":"2542_CR17","first-page":"88","volume":"71","author":"RD Arjona-Villica\u00f1a","year":"2014","unstructured":"Arjona-Villica\u00f1a RD, Herrera-S\u00e1nchez LF, Sum\u00e1rraga-Ugalde C, Ma A-G. Asociaci\u00f3n entre el \u00edndice de masa corporal y el perfil de l\u00edpidos en ni\u00f1os y adolescentes mexicanos con obesidad: un an\u00e1lisis retrospectivo. [Association between body mass index and lipid profile in Mexican children and adolescents with obesity: A retrospective analysis.]. Boll Med Hosp Infant Mex. 2014;71(2):88\u201394.","journal-title":"Boll Med Hosp Infant Mex"},{"issue":"5","key":"2542_CR18","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/j.jacl.2015.06.008","volume":"9","author":"REW Kavey","year":"2015","unstructured":"Kavey REW. Combined dyslipidemia in childhood. J Clin lipido. 2015;9(5):S41\u201356. https:\/\/doi.org\/10.1016\/j.jacl.2015.06.008.","journal-title":"J Clin lipido"},{"issue":"6","key":"2542_CR19","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1001\/archinte.163.6.705","volume":"163","author":"DA Hill","year":"2003","unstructured":"Hill DA, Gridley G, Cnattingius S, et al. Mortality and cancer incidence among individuals with Down syndrome. Arch Intern Med. 2003;163(6):705\u201311. https:\/\/doi.org\/10.1001\/archinte.163.6.705.","journal-title":"Arch Intern Med"},{"issue":"3","key":"2542_CR20","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1017\/s0012162205000319","volume":"47","author":"SM Day","year":"2005","unstructured":"Day SM, Strauss DJ, Shavelle RM, Reynolds RJ. Mortality and causes of death in persons with Down syndrome in California. Dev Med Child Neurol. 2005;47(3):171\u20136. https:\/\/doi.org\/10.1017\/s0012162205000319.","journal-title":"Dev Med Child Neurol"},{"issue":"3","key":"2542_CR21","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1056\/NEJM198601163140302","volume":"314","author":"WP Newman 3rd","year":"1986","unstructured":"Newman WP 3rd, Freedman DS, Voors AW, et al. Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. The Bogalusa heart study. N Engl J Med. 1986;314(3):138\u201344. https:\/\/doi.org\/10.1056\/NEJM198601163140302.","journal-title":"N Engl J Med"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-021-02542-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-021-02542-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-021-02542-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T15:17:32Z","timestamp":1620141452000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-021-02542-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,13]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2542"],"URL":"https:\/\/doi.org\/10.1186\/s12887-021-02542-1","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,13]]},"assertion":[{"value":"22 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This work was carried out in accordance with the World Medical Association\u2019s Helsinki Declaration, with Approval No. 2016\/040 from the Research and Research Ethics Boards of the National Institute of Pediatrics, Mexico City, Mexico, registered as IRB00008064 and IRB00008065 with the Office for Human Research Protection of the NIH (). A copy of the approval is available upon request. Informed assent (where possible) of participants and the written informed consent of parents or guardians was obtained.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"77"}}